A major shortcoming of postischemic therapy for myocardial infarction is the no‐reflow
phenomenon due to impaired cardiac microvascular function including microcirculatory …

Background Release of neutrophil extracellular traps (NETs) after percutaneous coronary
intervention (PCI) in acute coronary syndrome (ACS) is associated with periprocedural …

Cardiac reperfusion injury is a well-established outcome following treatment of acute
myocardial infarction and other types of ischemic heart conditions. Numerous …

The high incidence and mortality of acute myocardial infarction (MI) drastically threaten
human life and health. In the past few decades, the rise of reperfusion therapy has …

Despite improvements in revascularization after a myocardial infarction, coronary disease
remains a major contributor to global mortality. Neutrophil infiltration and activation …

Aim: No-reflow phenomenon (NRP) is an undesirable result of coronary interventions, and
usually occurred during the primary percutaneous coronary intervention (PPCI). On the other …

Background Successful restoration of epicardial coronary artery patency by primary
percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI) …

Background: Previous studies have shown conflicting results on the benefits of deferred
stenting (DS) in infarct size and the incidence of microvascular obstruction in patients with …

Background Coronary microvascular dysfunction and obstruction (CMVO) is a strong
predictor of a poor prognosis in patients with ST-segment elevation myocardial infarction …

Cardiac microvasculature and adverse remodeling after acute myocardial infarction. New
evidence on the use of VEGF as a therapeutic target Cardiac microvasculature and adverse …